AnOpen-Label Exploratory Clinical Trial Evaluating the Effects of GLS (Coptidis Rhizoma-Evodiae Fructus 2 : 1) on Fibroblast GrowthFactor21 inPatientswithNonalcoholicFattyLiverDisease